Finding answers, faster.

We exist to help our clients & patients to get access to medical solutions they need and deserve.

About Us

FutureMeds is a network of modern dedicated research sites conducting clinical trials. We are able to find significant numbers of eligible patients for trials across a wide variety of therapy areas, thus helping pharmaceutical companies and contract research organisations to run clinical trials as efficiently and cost effectively as possible.  Our priority is the safety and health of our patients and by helping to bring them future medicines today we can play a key part in improving health. We use innovative technologies to make clinical trials available for as many patients as possible by building their awareness of existing trials and simplifying their access to the latest medicine through the provision of home and virtual visits.

FutureMeds was founded by a team with unparalleled SMO experience and all our investigators are highly experienced in conducting general medicine clinical trials.

Meet The Team

If you would like to hear more about transforming your clinical trial process, please get in touch below.

Get in touch

Dr Radoslaw Janiak

Chief Executive Officer

  • LinkedIn

Radoslaw studied medicine at the University of Warsaw graduating in 1997. After working as a hospital doctor for 4 years he moved into clinical research initially as a site director for a Polish CRO.  Working for Synexus from 2005 until 2019 he was responsible for the rapid growth of the business across Central and Eastern Europe. He was appointed COO in 2015.

Christophe Berthoux

Chairman

  • LinkedIn

Christophe is a doctor in veterinary medicine and holds an MBA from Purdue University.  Christophe has spent his career within the CRO industry and worked for Charles River Laboratories between 1990 to 2010, ultimately holding the position of EVP, Chief Commercial Officer.  In 2010 he joined Synexus as CEO and transformed the business into the world’s largest SMO.  Following the successful sale of Synexus to PPD Christophe left the group and is now Chairman of IAG Group and an Operating Partner at ArchiMed.

Marcin Gondek

Chief Financial Officer

  • LinkedIn

Marcin is a graduate in Economics from the University of Wroclaw.  He spent 10 years working in senior finance roles for a number of multinational companies.  He joined Synexus in 2012, initially as finance director for Central and Eastern Europe and has extensive knowledge of site operations, feasibility and contracting.  Marcin was appointed as CFO of Synexus in 2017 and lead the integration of the European and US businesses.

Paul Chambers

Non-Executive Director

  • LinkedIn

Paul graduated from the University of Sheffield before training as a Chartered Accountant with KPMG.  He spent five years in Practice before moving into industry.  Formerly CFO of Synexus from 2010-2017, leading the business through a period of substantial growth culminating in two successful private equity exits. Paul is currently a non-executive director of The North West Fund.

Chris Hannigan

Non-Executive Director

  • LinkedIn

Chris graduated from the University of Kent with a degree in Mathematics.  He has spent 35 years in the clinical trials industry having held senior positions at Roche, P&G, Covance and Kendle (now part of Syneos), where he served as UK Managing Director.  Chris joined Synexus in 2007 and ultimately held the role of Chief Commercial Officer until his retirement in 2016.  Chris is currently a non-executive director of Simbec-Orion.

What we do

Therapy Areas

Contact us

Terms & Privacy Policy

info@futuremeds.com

Linked in

© 2020 Future Meds. All Rights Reserved. Poland, UK